TrialJournal of pharmacokinetics and pharmacodynamics2013

Dose selection using a semi-mechanistic integrated glucose-insulin-glucagon model: designing phase 2 trials for a novel oral glucokinase activator.

Xin Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.